BOSTON and CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system, ...

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today unveiled the launch of the Precision Pathology Network (PPN), a ...

If its hundreds of millions in venture funding and wide-ranging cadre of big-named partners are any indication, PathAI’s (ahem) path forward appears to be paved in gold. The five-year-old startup ...

Quest Diagnostics completed its previously announced acquisition of key assets from Boston biotech PathAI Diagnostics. In a June 11 press release, the Secaucus-based testing provider announced the ...

Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. The testing ...

PathAI, a leading provider of AI-powered pathology, will give a late-breaker presentation on new results from analytical and clinical validation studies that tested their AIM-NASHTM product and ...

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD Explore TM and AIM-HI UC TM at ...

BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the expansion of the AISight® Dx digital pathology ...

BOSTON, Mass., and TAMPA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top ...

BOSTON, Nov. 14, 2019 /PRNewswire-PRWeb/ -- PathAI, a leading provider of AI-powered technology for advancing pathology research, announced that it has appointed translational medicine and digital ...

Collaboration to produce a machine learning (ML)-based tool that automatically analyzes images of HER2 immunohistochemistry (IHC)-stained tissue slides and reports metrics that can be used to monitor ...

BOSTON--(BUSINESS WIRE)--PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today that it has raised $60 million in Series B funding. The round was led by ...